Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 50 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 8716460

    Pseudomonas AVR and HOP proteins, their encoding nucleic acids, and use thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted May 6, 2014 · Expires May 1, 2034

    granted

  2. US 8716301

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted

  3. US 8715686

    Conformationally stabilized HIV envelope immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted

  4. US 8709813

    DNA promoters and anthrax vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  5. US 8710026

    MiR 204, miR 211, their anti-miRs, and therapeutic uses of same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  6. US 8703150

    Methods of using Bacillus anthracis protective antigen sequences for vaccination

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  7. US 8703921

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  8. US 8697046

    Methods of administering interferon gamma to absorb fluid from the subretinal space

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  9. US 8697666

    Anti-cancer oligodeoxynucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  10. US 8691943

    Antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  11. US 8685722

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  12. US 8685396

    Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  13. US 8686016

    Schweinfurthins and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  14. US 8685416

    Compositions and methods for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  15. US 8680065

    Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  16. US 8680056

    Antiproliferative factor and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  17. US 8673316

    Avirulent, immunogenic flavivirus chimeras

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  18. US 8673333

    Cross-linked polymer matrices, and methods of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  19. US 8663622

    Recombinant vaccine viruses expressing IL-15 and methods using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  20. US 8664183

    SPANX-B polypeptides and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  21. US 8652787

    Use of ERBB4 as a prognostic and therapeutic marker for melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  22. US 8647818

    Molecular scaffolds for HIV-1 immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services (Hereinafter the Government) Office of Technology Transfer, National Institutes of Health · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  23. US 8637310

    Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  24. US 8637036

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.